1. Home
  2. NVAX vs PWP Comparison

NVAX vs PWP Comparison

Compare NVAX & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.30

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Perella Weinberg Partners

PWP

Perella Weinberg Partners

HOLD

Current Price

$21.10

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
PWP
Founded
1987
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
NVAX
PWP
Price
$8.30
$21.10
Analyst Decision
Hold
Hold
Analyst Count
9
3
Target Price
$10.78
$22.33
AVG Volume (30 Days)
6.4M
1.1M
Earning Date
02-26-2026
02-06-2026
Dividend Yield
N/A
1.27%
EPS Growth
N/A
N/A
EPS
2.07
0.70
Revenue
$1,064,651,000.00
$757,415,000.00
Revenue This Year
$58.91
N/A
Revenue Next Year
N/A
$41.37
P/E Ratio
$4.20
$31.81
Revenue Growth
20.27
N/A
52 Week Low
$5.01
$14.12
52 Week High
$10.65
$26.94

Technical Indicators

Market Signals
Indicator
NVAX
PWP
Relative Strength Index (RSI) 49.48 54.50
Support Level $9.16 $21.46
Resistance Level $10.20 $22.88
Average True Range (ATR) 0.69 1.00
MACD -0.09 -0.05
Stochastic Oscillator 22.67 52.88

Price Performance

Historical Comparison
NVAX
PWP

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

Share on Social Networks: